Steven Schroeder, MD

Stanford University, 1956-1960, B.A.
Harvard University, 1960-1964, M.D.
Harvard University, Res., 1964-1966, Medicine
Harvard University, Fellow, 1968-1971, Medicine

• 1966-1968
  Epidemic Intelligence Officer, Chief, Salmonellosis Unit, Bacterial Diseases Section, Epidemiology Program, National Communicable Diseases Center, U.S. Public Health Service
• 1970-1971
  Instructor in Medicine, Harvard Medical School
• 1971-1974
  Assistant Professor of Medicine The George Washington University Medical Center
• 1974-1976
  Associate Professor, Departments of Health Care Sciences and Medicine, The George Washington University Medical Center
• 1976-1980
  Associate Professor, Department of Medicine University of California, San Francisco
• 1980-1990
  Professor of Medicine, University of California, San Francisco Founding Chief, Division of General Internal Medicine, University of California, San Francisco
• 1982-1983
  Visiting Professor, Department of Community Medicine St. Thomas's Hospital Medical School, London, England
• 1990-2002
  President and CEO; and Member, Board of Trustees, The Robert Wood Johnson Foundation
• 1990-2002
  Clinical Professor of Medicine, Robert Wood Johnson Medical School of the University of Medicine and Dentistry of New Jersey
• 2003-present
  Distinguished Professor of Health and Health Care, Department of Medicine; Director, Smoking Cessation Leadership Center-- University of California, San Francisco

• 2002
  Second Century Award for Excellence in Health Care, Columbia University School of Nursing
• 2002
  Special Recognition Award, Association of American Medical Colleges
• 2003
  Champion Award, Youth Advocates of the Year Awards, Campaign for Tobacco-Free Kids
• 2003
  Alvin P. Shapiro Award, American Psychosomatic Society Annual Scientific Meeting
• 2003
  The Award of Honor, American Hospital Association
• 2004
  National Public Health Hero, University of California, Berkeley, School of Public Health
• 2006
  American Legacy Foundation names tobacco research center after Steven A Schroeder
• 2007
  James D. Bruce Memorial Award, American College of Physicians
• 2007
  James D Bruce Memorial Award for Distinguished Contributions in Preventive Medicine, American College of Physicians
• 2007
  Shattuck Lecturer, New England Journal of Medicine and Massachusetts Medical Society
• 2008
  Smoke Free Champion, The Smoke Free Project, Children's National Medical Center
• 2008
  Board of Directors Award of Honor, American Society of Health-System Pharmacists
• 2008
  Shattuck Lecture Panelist, New England Journal of Medicine and Massachusetts Medical Society-Health of the Nation-Coverage for All Americans
• 2008
  David E. Rogers Award, Association of American Medical Colleges

• Schroeder SA, Terry PM, and Bennett JV. Antibiotic Resistance and Transfer Factor in Salmonella, United States, 1967. JAMA. 205:903 906, 1968.
• Schroeder SA, Aserkoff B, and Brachman PS. Epidemic Salmonellosis in Hospitals and Institutions A Five Year Review. New England Journal of Medicine. 279:674-678, 1968.
• Schroeder SA, Kenders K, Cooper JK, and Piemme TE. Use of Laboratory Tests and Pharmaceuticals: Variation Among Physicians and Effect of Cost Audit on Subsequent Use. JAMA. 225:969 973, 1973.
• Schroeder SA and Showstack JA. Financial Incentives to Perform Medical Procedures and Laboratory Tests: Illustrative Models of Office Practice. Medical Care. 16:289 298, 1978.
• Schroeder SA and Showstack JA. Merchandising Cigarettes in Pharmacies: A San Francisco Survey. American Journal of Public Health. 68:494 495, 1978.
• Schroeder SA, Showstack JA and Roberts HE. Frequency and Clinical Description of High Cost Patients in 17 Acute Care Hospitals. New England Journal of Medicine. 300:1306 1309, 1979.
• Lo B and Schroeder SA. Frequency of Ethical Dilemmas on a Medical In Patient Service. Archives of Internal Medicine. 141:1062 1064, 1981.
• Schroeder SA, Showstack JA and Schwartz J. Survival of Adult High Cost Patients: Report of a Follow Up Study from Nine Acute Care Hospitals. JAMA. 245:1446 1449, 1981.
• Showstack JA, Schroeder SA and Matsumoto MF. Changes in the Use of Medical Technologies, 1972 1977: A Study of Ten Inpatient Diagnoses. New England Journal of Medicine. 306:706 712, 1982.
• Schroeder SA, Myers LP, McPhee SJ, Showstack JA, Simborg DW, Chapman SA and Leong JK. The Failure of Physician Education as a Cost Containment Strategy: Report of a Prospective Controlled Trial at a University Hospital. JAMA. 252:225 230, 1984.
• Schroeder SA. Western European Responses to Physician Oversupply: Lessons for the United States. JAMA. 252:373 384, 1984.
• Schroeder SA. A Comparison of Western European and US University Hospitals. A Case Report From Leuven, West Berlin, Leiden, London and San Francisco. JAMA. 252:240 246, 1984.
• Showstack JA, Hughes Stone M, and Schroeder S. The Role of Changing Clinical Practices in the Rising Costs of Hospital Care. New England Journal of Medicine. 313:1201 1207, 1985.
• Schroeder SA, Showstack JA, Gerbert BE. Residency Training in Internal Medicine: Time for a Change? Annals of Internal Medicine. 104:554 561, 1986.
• Schroeder SA: Expanding the Site of Clinical Education -- Moving Beyond the Hospital Walls. Journal of General Internal Medicine. 3:S5 S14, 1988.
• Katz MI, Schroeder SA: The Sounds of the Hospital: A Study of Beeper Use in Three Teaching Institutions. New England Journal of Medicine. 319:1585 1589, 1988.
• Schroeder SA, Zones JS, Showstack JA: Academic Medicine as a Public Trust. JAMA. 262:803 812, 1989.
• Lohr KN, Schroeder SA: A Strategy for Quality Assurance in Medicare. The New England Journal of Medicine. 322:707 712, 1990.
• Schroeder SA. The Troubled Profession: Is Medicine's Glass Half Full or Half Empty? Annals of Internal Medicine, 116:583 592, 1992.
• Schroeder SA, The Medically Uninsured: Will They Always be With Us? New England Journal of Medicine. 334:1130-1133, 1996.
• Schroeder SA. Mixed News from the Tobacco Wars. Editorial. NEJM. 347:1106-09, October 3, 2002.
• Schroeder SA. Tobacco Control in the Wake of the 1998 Master Settlement Agreement. New England Journal of Medicine, 350:293-301, 2004.
• Schroeder SA. The Tobacco Bailout and the FDA. Perspectives. New England Journal of Medicine, 30;351(14):1377-80, 2004.
• Eule B, Sullivan MK, Schroeder S, Hudmon KS. Merchandising Cigarettes in San Francisco pharmacies: 27 years Later. Tobacco Control 2004; 13(4):429-432.
• Schroeder SA. What To Do With a Patient Who Smokes. JAMA 294(4):482-7, 2005.
• Revell CC, Schroeder SA. Simplicity Matters: Using System-Level Changes To Encourage Clinician Intervention In Helping Tobacco Users Quit. Nicotine & Tobacco Research. Suppl 1:S67-9, 2005.
• Schroeder SA. An Agenda To Combat Substance Abuse. Health Aff (Millwood).24(4):1005-13, 2005.
• Hudmon KS, Fenlon CM, Corelli RL, Prokhorov AV, Schroeder SA. Tobacco Sales In Pharmacies: Time To Quit. Tobacco Control, in press.
• Schroeder SA. Should emergency departments help smokers quit? Editorial. Annals Emergency Medicine, 48:415-16, 2006.
• Schroeder SA and Sox HC. Varenicline: a new designer drug to help smokers quit. Annals of Internal Medicine 145:784-85, 2006.